A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa
Clinical trial NCT04019041 · COMPLETED
Trial details
- NCT number
- NCT04019041
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2020-05-19
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.